🌟 Meet Our Lab Stars: Agilent Instrument Edition 🌟 Annelies Ondersma from the UC San Diego Agilent Center of Excellence in Cellular Intelligence team is utilizing an Agilent LC/MS system they have called "Buzz" for her research in gastric cancer and mother infant metabolite studies. This instrument provides the precision, versatility, and sensitivity necessary for such a wide range of applications, some might say almost infinite! “We named the LC/MS Buzz because it is capable of parts per quadrillion level analyte detection,” said Annelise. “... and, true to the tagline of that [famous] space ranger, its applications in proteomics and metabolomics are nearly limitless.” Discover more Lab Stars from around the globe: https://bit.ly/3CNIEmd #GreatScience #LabStars #UCSD
Agilent Technologies
Biotechnology Research
Santa Clara, CA 592,280 followers
Let’s Bring Great Science to Life.
About us
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio. Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories. Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life. In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
- Website
-
http://www.agilent.com
External link for Agilent Technologies
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Santa Clara, CA
- Type
- Public Company
- Founded
- 1999
- Specialties
- Diagnostics & Genomics, Chemical Analysis, Life Sciences, Environmental & Forensics, Food Safety, Pharmaceutical, Cancer Research, Pathology, Agriculture, Clinical Diagnostics, and Biopharma
Locations
Employees at Agilent Technologies
Updates
-
Testing for PFAS in environmental samples? Check out our PFAS workflow ordering guide for end-to-end solutions covering various methods and applications, including drinking water, wastewater, ground and surface water, soil, and other complex environmental matrices. Get the guide: https://bit.ly/3SbEdWb
-
-
Listen to Gary Patti, Professor at Washington University, speak on the topic, "Metabolite imaging signals the next frontier in spatial biology" on Nov 12, 2024. Register for webinar: https://bit.ly/4e8yIka
-
-
The new Agilent fully demountable torch with alumina injector resists degradation when analyzing lithium-ion battery materials. Find out more: https://bit.ly/4ekOwB4
-
-
A new eBook highlights how Agilent solutions can address increasingly stringent regulatory requirements for pharmaceutical impurities, including extractables and leachables, nitrosamines, residual solvents, and elemental contaminants. The document provides easy access to the latest regulations, proven end-to-end workflows, and new developments in chromatography, mass spectrometry, and elemental analysis platforms that can simplify testing and exceed requirements. Read more at: https://bit.ly/3XqdW9b #gaschromatography #hplc #gcms #lcms #pharmaceuticaltesting
-
-
The Agilent team again executed well and delivered solid results in the fourth quarter. In Q4, we completed our acquisition of BIOVECTRA; revolutionized HPLC with the launch of the Infinity III LC Series; and released our new J&W 5Q GC/MS Columns, one of our most significant advancements in the technology. Agilent also was recently ranked no. 11 on Fortune’s list of Best Workplaces in the World. See our full results and FY25 guidance: https://bit.ly/4eLg9mb Join our Analyst and Investor Day on Dec. 17 to learn more about exciting developments at Agilent, including our new market-based, customer-first strategy and our transformation: https://bit.ly/4i3s4yO
-
Agilent today announced a new organizational structure to accelerate our operational transformation to drive higher growth through a market-focused, customer-centric enterprise strategy. Read more: https://bit.ly/3YZ1Ep8
-
Need answers for frequently asked questions on ultra-high vacuum (UHV) and extreme high vacuum (XHV)? Watch the Agilent 2-minute Tutorial Video Series here: https://bit.ly/3LRF7Ex
-
Peptide therapeutics represent a new frontier in pharmaceutical development. Agilent provides a comprehensive suite of analytical systems, software, consumables and services designed to support the development of these innovative therapies. Find complete methods to deliver accuracy and efficiency, from discovery through to quality control and beyond: https://bit.ly/3zHtrlp
-
-
Missed the ASMS conference? No worries! Catch up on the latest breakthroughs and trends by watching our webinar recordings. Gain valuable insights from industry leaders and stay ahead in the ever-evolving world of mass spectrometry: https://bit.ly/3zzxgZQ #MassSpectrometry #Innovation #ASMS #Webinars #IndustryInsights #StayAhead
-
Affiliated pages
Similar pages
Browse jobs
Stock
A
NYSE
20 minutes delay
$138.14
3.77 (2.806%)
- Open
- 134.69
- Low
- 134.235
- High
- 139
Data from Refinitiv
See more info on